Welcome to QBiotics
- We are an unlisted Australian public company.
- We discover, develop and commercialise novel anticancer and wound healing pharmaceuticals for human and veterinary markets.
- Our lead drug, tigilanol tiglate, is a small molecule anticancer pharmaceutical targeting a range of solid tumours across multiple species.
- The simultaneous development of products for both the vet and human markets enables validation of technology and reduces risks for human development, while generating early revenues.
Human Oncology
Veterinary
Commercialisation
Commercialisation
Financial Health